C3a receptor

The C3a receptor also known as complement component 3a receptor 1 (C3AR1) is a G protein-coupled receptor protein involved in the complement system.[5][6]

C3AR1
Identifiers
AliasesC3AR1, AZ3B, C3AR, HNFAG09, complement component 3a receptor 1, complement C3a receptor 1
External IDsOMIM: 605246 MGI: 1097680 HomoloGene: 2992 GeneCards: C3AR1
Gene location (Human)
Chr.Chromosome 12 (human)[1]
Band12p13.31Start8,056,844 bp[1]
End8,066,359 bp[1]
RNA expression pattern
More reference expression data
Orthologs
SpeciesHumanMouse
Entrez

719

12267

Ensembl

ENSG00000171860

ENSMUSG00000040552

UniProt

Q16581

O09047

RefSeq (mRNA)

NM_004054
NM_001326475
NM_001326477

NM_009779

RefSeq (protein)

NP_001313404
NP_001313406
NP_004045

NP_033909

Location (UCSC)Chr 12: 8.06 – 8.07 MbChr 6: 122.85 – 122.86 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

The receptor binds to complement component C3a, although there is limited evidence that this receptor also binds C4a in lesser mammals this has yet to be proven true in humans.[7] C3a receptor modulates immunity,[8] arthritis, diet-induced obesity[9] and cancers[10]

Agonists and antagonists

Potent and selective agonists[11] and antagonists[12] for C3aR have been discovered.

gollark: --userdata delete bee bee2
gollark: --userdata delete bee bee2
gollark: --userdata list
gollark: --roll 3d6
gollark: --userdata inc test 5

References

  1. GRCh38: Ensembl release 89: ENSG00000171860 - Ensembl, May 2017
  2. GRCm38: Ensembl release 89: ENSMUSG00000040552 - Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. Roglic A, Prossnitz ER, Cavanagh SL, Pan Z, Zou A, Ye RD (February 1996). "cDNA cloning of a novel G protein-coupled receptor with a large extracellular loop structure". Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1305 (1–2): 39–43. doi:10.1016/0167-4781(95)00209-x. PMID 8605247.
  6. Ali H, Panettieri RA (February 2005). "Anaphylatoxin C3a receptors in asthma". Respiratory Research. 6: 19. doi:10.1186/1465-9921-6-19. PMC 551592. PMID 15723703.
  7. Klos A, Wende E, Wareham KJ, Monk PN (January 2013). "International Union of Basic and Clinical Pharmacology. [corrected]. LXXXVII. Complement peptide C5a, C4a, and C3a receptors". Pharmacological Reviews. 65 (1): 500–43. doi:10.1124/pr.111.005223. PMID 23383423.
  8. Cravedi P, Leventhal J, Lakhani P, Ward SC, Donovan MJ, Heeger PS (October 2013). "Immune cell-derived C3a and C5a costimulate human T cell alloimmunity". American Journal of Transplantation. 13 (10): 2530–9. doi:10.1111/ajt.12405. PMC 3809075. PMID 24033923.
  9. Lim J, Iyer A, Suen JY, Seow V, Reid RC, Brown L, Fairlie DP (February 2013). "C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling". FASEB Journal. 27 (2): 822–31. doi:10.1096/fj.12-220582. PMID 23118029.
  10. Sayegh ET, Bloch O, Parsa AT (August 2014). "Complement anaphylatoxins as immune regulators in cancer". Cancer Medicine. 3 (4): 747–58. doi:10.1002/cam4.241. PMC 4303144. PMID 24711204.
  11. Reid RC, Yau MK, Singh R, Hamidon JK, Reed AN, Chu P, Suen JY, Stoermer MJ, Blakeney JS, Lim J, Faber JM, Fairlie DP (2013). "Downsizing a human inflammatory protein to a small molecule with equal potency and functionality". Nature Communications. 4: 2802. doi:10.1038/ncomms3802. PMID 24257095.
  12. Reid RC, Yau MK, Singh R, Lim J, Fairlie DP (August 2014). "Stereoelectronic effects dictate molecular conformation and biological function of heterocyclic amides". Journal of the American Chemical Society. 136 (34): 11914–7. doi:10.1021/ja506518t. PMID 25102224.

Further reading

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.